Cargando…
Suppressive Role of Androgen/Androgen Receptor Signaling via Chemokines on Prostate Cancer Cells
Androgen/androgen receptor (AR) signaling is a significant driver of prostate cancer progression, therefore androgen-deprivation therapy (ADT) is often used as a standard form of treatment for advanced and metastatic prostate cancer patients. However, after several years of ADT, prostate cancer prog...
Autores principales: | Izumi, Kouji, Mizokami, Atsushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463189/ https://www.ncbi.nlm.nih.gov/pubmed/30871130 http://dx.doi.org/10.3390/jcm8030354 |
Ejemplares similares
-
Androgen Deprivation Therapy in High-Risk Localized and Locally Advanced Prostate Cancer
por: Iwamoto, Hiroaki, et al.
Publicado: (2022) -
α-Trifluoromethyl Chalcones as Potent Anticancer Agents for Androgen Receptor-Independent Prostate Cancer
por: Saito, Yohei, et al.
Publicado: (2021) -
Bicyclic Chalcones as Mitotic Inhibitors for Overcoming
Androgen Receptor-Independent and Multidrug-Resistant Prostate Cancer
por: Saito, Yohei, et al.
Publicado: (2021) -
Suppression of androgen receptor signaling induces prostate cancer migration via activation of the CCL20–CCR6 axis
por: Kano, Hiroshi, et al.
Publicado: (2022) -
Targeting the androgen receptor with siRNA promotes prostate cancer metastasis through enhanced macrophage recruitment via CCL2/CCR2-induced STAT3 activation
por: Izumi, Kouji, et al.
Publicado: (2013)